Expectant management of patent ductus arteriosus noninferior to early ibuprofen use
1. In this randomized controlled trial, expectant management of patent ductus arteriosus (PDA) in extremely premature infants required no active intervention unless complications arose. 2. Expectant management was shown to be noninferior to early ibuprofen in terms of preventing adverse neonatal outcomes. Evidence Rating Level: 1 (Excellent) Study Rundown: PDA is a common complication of
Source: 2minutemedicine.com
